PRAGUE, Czech Republic, April 24, 2018 -- This week at the industry’s premier flow cytometry conference, CYTO 2018, Cytek Biosciences Inc. will be on the show floor highlighting its CytekTM Aurora flow cytometry system with enhanced features. This unique platform has been embraced by researchers around the world since making its debut at CYTO 2017, and the deployments so far have been validating the application flexibility of the Cytek Aurora. From extra-cellular vesicles to highly multiparametric applications beyond what were initially envisioned and more, the breadth of applications being performed on the Cytek Aurora continues to grow.
“At this time last year, we introduced the scientific community to an all-new full spectrum flow cytometer that enables new discoveries and deeper biological insights at an affordable cost,” noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Now, Cytek Aurora has been sold into four continents and is at work all over the globe. CYTO 2018 is the perfect place for us to showcase how we have expanded Cytek Aurora’s features and application abilities over the past year and set the stage for future innovations to come.”
Cytek Aurora offers capabilities that go beyond flow cytometry systems that come with a much higher price tag. With a simplified workflow, greater flexibility, and a lower cost of ownership, the Cytek Aurora is the embodiment of Cytek’s mission to make high end, high quality flow cytometry accessible to a larger number of researchers.
Cytek Aurora will be demonstrated at CYTO 2018 in Prague, Czech Republic, from April 28 – May 2 at booth #33. CYTO attendees are also encouraged to learn more about the Cytek Aurora through the following CYTO events and displays:
-
- Wednesday, May 2 – Commercial Tutorial: ‘Expanding Application Capabilities Using Full Spectrum Cytometry’
- Poster: ‘Minimizing the Effects of Spectral Overlap by Unmixing Versus Compensation,’ Program Number: 294. Poster Board Number: B289.
Please visit www.cytekbio.com for more information.
About Cytek Biosciences
Cytek Biosciences Inc. is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. To learn more, visit www.cytekbio.com and follow them on LinkedIn.
Media Contact:
Justine Houston-Brown
Lages & Associates
(949) 453-8080
[email protected]
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/0c0b45d4-94bf-44ef-bcd8-8c3cf3b572ad


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



